Introduction {#s1}
============

One of the most challenging health problems of the twenty-oneth century is type 2 diabetes mellitus (T2DM). It represents a significant disease burden on human beings, both in developed and developing countries [@pone.0059495-vanDieren1], and now affects 285 million people all over the world. More importantly, its prevalence is increasing rapidly over the next decade owing to human longevity and surge of obesity in many countries including China [@pone.0059495-Shaw1].

T2DM is a complex metabolic disease that results from the combination of genetic and environmental factors [@pone.0059495-Hansen1]. Grant and colleagues [@pone.0059495-Grant1] reported on the association of transcription factor 7-like 2 (TCF7L2) polymorphism with T2DM in an Icelandic case-control sample. From then on, the TCF7L2 gene is regarded as one of the most important genes in determining the genetic susceptibility for T2DM in Europeans [@pone.0059495-Grant1]--[@pone.0059495-Potapov1], West Africans [@pone.0059495-Helgason1], Mexican Americans [@pone.0059495-Lehman1], Southern Asians [@pone.0059495-Chandak1], and Chinese [@pone.0059495-Chen1]--[@pone.0059495-Zhao1]. However, conflicting results in Chinese Han population [@pone.0059495-Chen1]--[@pone.0059495-Fan1], [@pone.0059495-Chang1], [@pone.0059495-Zhang1] are often reported because of it's intricately substructure [@pone.0059495-Xu1].

In this work, we conducted a meta-analysis with large samples based on the representative single nucleotide polymorphisms in Chinese Han population, which have already been much studied. The meta-analysis method using all available studies has proved to be more powerful and can lead to more reliable conclusion in comparison with a single study. Therefore, we employed this method to evaluate the association between TCF7L2 polymorphisms and the T2DM risk in Chinese Han population.

Materials and Methods {#s2}
=====================

Our study followed the statement of PRISMA for reporting systematic review and meta-analysis [@pone.0059495-Moher1].

Search Strategy {#s2a}
---------------

In this meta-analysis, we searched literature from the following databanks: China National Knowledge Infrastructure (CNKI), PubMed, Embase, Elsevier, Springer Link, Cochrane Library, and ISI Web of Science. The searching languages included English and Chinese. The employed key words and subject terms were TCF7L2, transcription factor 7-like 2, rs7903146, rs12255372, rs11196218, rs11196205, rs7901695, rs290487, gene polymorphism, diabetes mellitus, type 2, type 2 diabetes mellitus, T2DM, and T2D. Furthermore, the reference lists of thus-obtained eligible studies and relevant review papers were identified by a manual search on this topic. The last research was updated until August 15, 2012.

Inclusion and Exclusion Criteria {#s2b}
--------------------------------

The primary studies included in our meta-analysis should meet the following criteria: (1) the association between TCF7L2 polymorphisms (rs7903146, rs12255372, rs11196218, rs11196205, rs7901695, and rs290487) and T2DM risk in Chinese Han population should be clearly evaluated; (2) the studies must be of case-control study; (3) the papers should clearly describe the diagnoses of T2DM and the sources of cases and controls; (4) the studies should provide original data and sufficient information to estimate odds ratio (*OR*) and corresponding 95% confidence interval (*CI*). The following studies were excluded: (1) those contained duplicate data; (2) those reported in the form of abstract, comment, and review; (3) those except for that using the largest samples, if the identical group published more than one articles based on the same data series.

Quality Assessment {#s2c}
------------------

The Newcastle-Ottawa Scale (NOS) [@pone.0059495-Wells1] was used to assess the quality of the studies employed in this work. The NOS contains eight items. It is categorized into three dimensions including selection, comparability, and exposure for case-control studies. The selection contains four items, the comparability contains one item, and the exposure contains three items. A star system is used to allow a semi-quantitative assessment of study quality. A study can be awarded a maximum of one star for each numbered item within the selection and exposure categories. A maximum of two stars can be given for comparability. In our meta-analysis, the region was regarded as the most important confounder factor, while the age, sex, and body mass index (BMI) as the second important. The NOS ranges from zero up to nine stars. High quality study should be achieve more than seven stars, medium quality study between four to six stars and poor-quality study less than four stars.

Data Extraction {#s2d}
---------------

For quality control, data were extracted from the studies independently by two of our authors. If the information of genotype distribution was inadequate, we tried to contact the authors of the related paper. The following information was extracted from each article: the last name of the first author, publishing year, region, numbers of cases and controls, numbers of genotypes for cases and controls, and Hardy-Weinberg equilibrium (HWE) in each control group. Any disagreement between our two authors was resolved by consulting the third.

Ethics Statement {#s2e}
----------------

This article was on a meta-analysis. We got the data from previous studies. All the data were analyzed anonymously. We confirmed that all the data did not involve competing interest.

Statistical Analysis {#s2f}
--------------------

In this study, we performed both overall and subgroup meta-analysis. In both kinds of the meta-analysis, pooled odds ratios (*OR*) and 95% confidence interval (*CI*) were used to assess the strength of the association between polymorphisms of TCF7L2 and T2DM risk, which were calculated by fixed-effect model or a random effect model chosen based on the heterogeneity test [@pone.0059495-Lau1]. When the heterogeneity test of *χ^2^*-based *Q*-test reported a *P* value of more than 0.10, we used the fixed-effect model [@pone.0059495-Mantel1]; otherwise a random effect model was performed [@pone.0059495-DerSimonian1]. Heterogeneity was also assessed by *I^2^* test. The *I^2^* statistic was documented for the percentage of the observed study variability due to heterogeneity rather than chance. (*I^2^* = 0--25%, no heterogeneity; *I^2^* = 25--50%, moderate heterogeneity; *I^2^* = 50--75%, large heterogeneity; *I^2^* = 75--100%, extreme heterogeneity) [@pone.0059495-Higgins1]. In addition, statistical significance of the association between polymorphism and T2DM risk was calculated by *Z*-test. When the *Z*-test reported a *P* \< 0.05, there was statistical significance for the association.

The subgroup meta-analysis was employed to reveal the effect of different regions on the overall estimation of the association. The whole region of China was divided into two parts with the Yangtze River as the boundary [@pone.0059495-Xu2]. The northern region was on the north of the boundary, and the southern on the south. Additionally, other kinds of subgroup analyses were conducted based on the variables like age, sex, and BMI, respectively. As an example for age, the studies showing statistical significance in age (*P*\<0.05) between the cases and the controls were assigned to the incomparability subgroup of age, while those with *P*\>0.05 were assigned to comparability subgroup. The subgroup analysis was also performed based on Hardy-Weinberg equilibrium (HWE). As HWE is the principal law of the population genetic studies, we calculated *p* value of HWE for the control group of each study based on the Pearson chi-square. If the *P*\>0.05, the focus would conform to HWE and the samples of control would be representative.

A sensitivity analysis was carried out to assess the stability of the meta-analysis results. That is to say, by omitting one case--control study at a time, the pooled OR for the remaining studies was computed. If the pooled OR was not changed by the single study, this result would be stability.

In our literature, funnel plots were used to evaluate publication bias. All *P*-values were two-tailed. The Review Manager 5.0 software (2011, Cochrane Collaboration) was used to carry out the meta-analysis.

Results {#s3}
=======

Studies and Data Included in this Meta-analysis {#s3a}
-----------------------------------------------

[Fig. 1](#pone-0059495-g001){ref-type="fig"} shows the flow for searching and selecting eligible literature. After removal of the publications of duplicates, reviews, abstracts, and comments, 20 case-control studies [@pone.0059495-Chen1]--[@pone.0059495-Zhang1], [@pone.0059495-Ng1]--[@pone.0059495-Zhu1] with 9122 cases of T2DM and 8017 controls were identified for recruitment in the light of the inclusion criteria. All these studies were published from 2007 to 2012.

![Flow for the selection of eligible studies.](pone.0059495.g001){#pone-0059495-g001}

[Table 1](#pone-0059495-t001){ref-type="table"} shows 13 eligible studies for rs7903146 with 6427 cases of T2DM and 6114 controls, which were included in this analysis. [Table 2](#pone-0059495-t002){ref-type="table"} summarizes 5 eligible studies for rs12255372 with 2294 cases of T2DM and 1957 controls. [Table 3](#pone-0059495-t003){ref-type="table"} shows 8 studies for rs290487 with 2141 cases of T2DM and 1727 controls. The characteristics of all the included studies are also listed in the tables, such as source of controls, HWE, and comparability of cases and controls. [Table 4](#pone-0059495-t004){ref-type="table"} summarizes the quality of all the included studies assessed by NOS. Most studies were of high quality in terms of selection and exposure. However, as for comparability, the quality was relativity low, since most of the cases were not quite comparable with the controls on age, sex, and BMI.

10.1371/journal.pone.0059495.t001

###### The basic characteristics of the included studies for rs7903146.

![](pone.0059495.t001){#pone-0059495-t001-1}

  First author    Publishing year    Region             Source of controls           Sample sizes   Case   Control   HWE   Comparability                         
  -------------- ----------------- ----------- ------------------------------------ -------------- ------ --------- ----- --------------- --- ----- ------ ----- -------------------------
  Chang                2007          Taiwan               Hospital-based                 760        760       1      35         724        0   44    716    Yes   Age\*\*,sex\*\*,BMI\*\*
  Ng                   2007         HongKong    community-based and hospital staff       433        419       1      24         408        0   20    399    Yes    Age\*, sex\*, BMI\*\*
  Zeng                 2007          Chengdu              Hospital staff                  92         80       0       8         84         0    2     78    Yes      Age\* and BMI\*\*
  Ren                  2008          Beijing              Hospital-based                 500        500       2      41         438        2   26    463    No    Age\*\*,sex\*\*,BMI\*\*
  Wang                 2008         Chongqing             Hospital-based                 446        303       8      67         371        1   24    278    Yes   Age\*\*,sex\*, BMI\*\*
  Lou                  2009          Jiangsu                   N/D                       682        551       0      49         633        0   25    526    Yes   Age\*,sex\*\*, BMI\*\*
  Wen                  2010         Shanghai                   N/D                       1165       1136      0      120       1045        3   68    1065   No      Age\*, sex\*, BMI\*
  Zhang                2010         Hengyang              Hospital-based                 236        218       0      23         213        0   15    203    Yes   Age\*\*,sex\*, BMI\*\*
  Lin                  2010          Chengdu              Hospital-based                 1529       1439      3      178       1348        4   107   1328   Yes   Age\*\*,sex\*, BMI\*\*
  Zhao                 2011          Qingdao              Hospital-based                  99        114       0      11         88         0    4    110    Yes    Age\*, sex\*, BMI\*\*
  Zheng                2011         Chongqing             Hospital-based                 227        152       1      24         202        0   13    139    Yes   Age\*,sex\*\*, BMI\*\*
  Chen                 2011           Hubei               Hospital-based                 258        239       9      57         192        4   33    202    Yes   Age\*\*,sex\*, BMI\*\*
  Zhang                2012         Shenyang                   N/D                       202        203       0      29         173        0   12    191    Yes    Age\*, sex\*, BMI\*\*

Abbreviations: HWE, Hardy--Weinberg equilibrium; Yes, the genotype distribution meet the HWE in control group; No, the genotype distribution not meet HWE in control group; community-based and hospital staff : subjects who were enrolled from community and hospital staff; Hospital-based: subjects who were enrolled from health check conducted in hospital; N/D: not description; \*: P\>0.05; \*\*: P\<0.05.

10.1371/journal.pone.0059495.t002

###### The basic characteristics of the included studies for rs12255372.

![](pone.0059495.t002){#pone-0059495-t002-2}

  First author    Publishing year    Region     Source of controls   Sample sizes   Case   Control   HWE    Comparability               
  -------------- ----------------- ----------- -------------------- -------------- ------ --------- ------ --------------- ------ ----- -------------------------
  Chang                2007          Taiwan       Hospital-based         760        760       9      1511         6         1514   Yes   Age\*\*,sex\*\*,BMI\*\*
  Ren                  2008          Beijing      Hospital-based         500        500       9      989          9         989    No    Age\*\*,sex\*\*,BMI\*\*
  Wang                 2008         Chongqing     Hospital-based         446        303      15      877          8         598    Yes   Age\*\*,sex\*, BMI\*\*
  Fan                  2009          Tianjin      Hospital-based         352        176      65      639          5         347    Yes    Age\*,sex\*, BMI\*\*
  Zhang                2010         Hengyang      Hospital-based         236        218      17      455         12         424    Yes   Age\*\*,sex\*, BMI\*\*

Abbreviations: HWE, Hardy--Weinberg equilibrium; Yes, the genotype distribution meet the HWE in control group; No, the genotype distribution not meet HWE in control group.

Hospital-based: subjects who were enrolled from health check conducted in hospital; \*: P\>0.05; \*\*: P\<0.05.

10.1371/journal.pone.0059495.t003

###### The basic characteristics of the included studies for rs290487.

![](pone.0059495.t003){#pone-0059495-t003-3}

  First author    Publishing year   Region    Source of controls   Sample sizes   Case   Control   HWE   Comparability              
  -------------- ----------------- --------- -------------------- -------------- ------ --------- ----- --------------- ----- ----- -------------------------
  Chang                2007         Taiwan      Hospital-based         760        760      635     885        552        968   Yes   Age\*\*,sex\*\*,BMI\*\*
  Ren                  2008         Beijing     Hospital-based         500        500      391     609        352        648   No    Age\*\*,sex\*\*,BMI\*\*
  Qiao                 2012         Harbin      Hospital-based         700        570      526     866        466        648   Yes     Age\*, sex\*, BMI\*
  Yu                   2010          Hunan           N/D               295        188      217     373        143        233   Yes    Age\*, sex\*, BMI\*\*
  Zhang^1^             2008          Jinan           N/D               100        100      79      121        72         128   Yes     Age\*, sex\*, BMI\*
  Zhang^2^             2008          Hunan      Hospital-based         536        475      380     664        374        552   Yes    Age\*, sex\*\*, BMI\*
  Zhu                  2011          Anhui      Hospital-based         300        300      248     352        205        395   Yes     Age\*, sex\*, BMI\*
  Zou                  2009         Yunnan           N/D               210         94      139     261        56         132   Yes   Age\*, sex\*, BMI^N/D^

Abbreviations: HWE, Hardy--Weinberg equilibrium; Yes, the genotype distribution meet the HWE in control group; No, the genotype distribution not meet HWE in control group.

Zhang^1^ : ZhangYong; Zhang^2^ : ZhangYing; Hospital-based: subjects who were enrolled from health check conducted in hospital; N/D: not description; \*: P\>0.05; \*\*: P\<0.05.

10.1371/journal.pone.0059495.t004

###### Quality assessment for all the included studies.

![](pone.0059495.t004){#pone-0059495-t004-4}

  First author    Publishing year   Selection   Comparability   Exposure
  -------------- ----------------- ----------- --------------- ----------
  Chang                2007            ☆☆☆            ☆           ☆☆☆
  Ng                   2007            ☆☆☆            ☆            ☆
  Zeng                 2007            ☆☆☆                         ☆☆
  Ren                  2008            ☆☆             ☆            ☆☆
  Wang                 2008            ☆☆☆            ☆            ☆☆
  Lou                  2009            ☆☆                          ☆☆
  Fan                  2009           ☆☆☆☆           ☆☆           ☆☆☆
  Wen                  2010            ☆☆             ☆           ☆☆☆
  Zhang                2010           ☆☆☆☆            ☆            ☆
  Lin                  2010            ☆☆             ☆            ☆☆
  Zhao                 2011           ☆☆☆☆           ☆☆            ☆
  Zheng                2011           ☆☆☆☆            ☆            ☆☆
  Chen                 2011            ☆☆☆            ☆           ☆☆☆
  Zhang                2012            ☆☆             ☆            ☆☆
  Qiao                 2012            ☆☆☆           ☆☆            ☆
  Yu                   2010            ☆☆             ☆            ☆☆
  Zhang^1^             2008            ☆☆☆            ☆            ☆☆
  Zhang^2^             2008            ☆☆             ☆            ☆☆
  Zhu                  2011           ☆☆☆☆           ☆☆            ☆☆
  Zou                  2009            ☆☆             ☆            ☆☆

Zhang^1^ : Yong Zhang; Zhang^2^ : Ying Zhang.

Association between rs7903146C/T Polymorphism and T2DM Risk {#s3b}
-----------------------------------------------------------

There was significant heterogeneity among the studies of rs7903146C/T in the overall meta-analysis. Therefore, the random effect model was employed to assess the association between rs7903146C/T polymorphism and T2DM risk. The evaluation result indicated that rs7903146C/T polymorphism was associated with T2DM risk (as shown in [Fig. 2](#pone-0059495-g002){ref-type="fig"}, T vs. C: *OR* = 1.73, 95% *CI = *1.39--2.16, *P*\<0.00001; heterogeneity test *χ* ^2^ = 30.32, *P = *0.003, *I* ^2^ = 60%).

![Forest plot of the association between rs7903146C/T polymorphism and T2DM risk (overall meta-analysis T vs. C).\
n indicates the total number of T allele, and N indicates the total number of T allele plus C allele.](pone.0059495.g002){#pone-0059495-g002}

The subgroup meta-analysis of the studies which conformed with HWE in the control groups showed that there was association between rs7903146C/T polymorphism and T2DM risk (as shown in [Fig. 3](#pone-0059495-g003){ref-type="fig"}, T vs. C: *OR* = 1.60, 95% *CI = *1.30--1.96, *P*\<0.00001; heterogeneity test *χ* ^2^ = 16.21, *P = *0.09, *I^2^* = 38%). The subgroup meta-analysis of different regions also confirmed that there was association between rs7903146C/T polymorphism and T2DM risk in both the northern and the southern China (as shown in [Fig. 4](#pone-0059495-g004){ref-type="fig"}, in the northern China: T vs. C: *OR* = 1.95, 95% *CI* = 1.36--2.82, *P = *0.0003; heterogeneity test *χ* ^2^ = 2.23, *P* = 0.33, *I^2^* = 10%; as shown in [Fig. 5](#pone-0059495-g005){ref-type="fig"}, in the southern China, T vs. C: *OR* = 1.66, 95% *CI = *1.28--2.15, *P* = 0.0001; heterogeneity test *χ* ^2^ = 27.79, *P = *0.001, *I^2^* = 68%).

![Forest plot of the association between rs7903146C/T polymorphism and T2DM risk (subgroup analyses for the HWE in the control groups: T vs. C).\
n indicates the total number of T allele, and N indicates the total number of T allele plus C allele.](pone.0059495.g003){#pone-0059495-g003}

![Forest plot of the association between rs7903146C/T polymorphism and T2DM risk (subgroup analyses for the northern: T vs. C).\
n indicates the total number of T allele, and N indicates the total number of T allele plus C allele.](pone.0059495.g004){#pone-0059495-g004}

![Forest plot of the association between rs7903146C/T polymorphism and T2DM risk (subgroup analyses for the southern: T vs. C).\
n indicates the total number of T allele, and N indicates the total number of T allele plus C allele.](pone.0059495.g005){#pone-0059495-g005}

By the subgroup meta-analysis of the studies based on the confounder factors like age and sex, it was illustrated that the association between rs7903146C/T polymorphism and T2DM was not affected by these two factors (the subgroup of age comparability: *OR* = 2.04, 95% *CI* = 1.46--2.84, *P*\<0.0001; heterogeneity test *χ* ^2^ = 11.56, *P* = 0.07, *I^2^* = 48%; the subgroup of age incomparability: *OR* = 1.52, 95% *CI* = 1.18--1.96, *P* = 0.001; heterogeneity test *χ* ^2^ = 10.88, *P* = 0.05, *I^2^* = 54%; the subgroup of sex comparability: *OR = *1.97, 95% *CI = *1.54--2.52, *P*\<0.00001; heterogeneity test *χ* ^2^ = 15.97, *P* = 0.03, *I^2^* = 56%; the subgroup of sex incomparability: *OR = *1.34, 95% *CI* = 0.95--1.88, *P* = 0.03; heterogeneity test *χ* ^2^ = 6.72, *P* = 0.15, *I^2^* = 40%.). The effect of the BMI on the association was not examined since there was only one study based on the comparability of BMI.

Association between rs12255372G/T Polymorphism and T2DM Risk {#s3c}
------------------------------------------------------------

Significant heterogeneity was found among the studies of rs12255372G/T in the overall meta-analysis. Thus, the random effect model was used to evaluate the association between rs12255372G/T polymorphism and T2DM risk. The evaluation result indicated that rs12255372G/T polymorphism was not associated with T2DM risk (as shown in [Fig. 6](#pone-0059495-g006){ref-type="fig"}, T vs. G: *OR* = 1.77, 95% *CI* = 0.88--3.56, *P* = 0.11; heterogeneity test *χ* ^2^ = 12.23, *P = *0.02, *I^2^* = 67%).

![Forest plot of the association between rs12255372G/T polymorphism and T2DM risk (overall meta-analysis T vs. G).\
n indicates the total number of T allele, and N indicates the total number of T allele plus G allele.](pone.0059495.g006){#pone-0059495-g006}

The subgroup meta-analysis of the studies which conformed with HWE in the control groups showed that there was no association between 12255372G/T polymorphism and T2DM risk (as shown in [Fig. 7](#pone-0059495-g007){ref-type="fig"}, T vs. G: *OR* = 2.04, 95% *CI* = 0.89--4.66, *P* = 0.09; heterogeneity test *χ* ^2^ = 10.49, *P* = 0.01, *I^2^* = 71%). The subgroup meta-analysis also demonstrated that there was no association between 12255372G/T polymorphism and T2DM risk in the southern China (as shown in [Fig. 8](#pone-0059495-g008){ref-type="fig"}, in the southern China, T vs. G: *OR* = 1.35, 95% *CI* = 0.82--2.21, *P* = 0.24; heterogeneity test *χ* ^2^ = 0.06, *P* = 0.97, *I^2^* = 0%). We did not evaluate such association for the subgroup of the northern China since there were not sufficient data.

![Forest plot of the association between rs12255372G/T polymorphism and T2DM risk (subgroup analyses for the HWE in the control groups: T vs. G).\
n indicates the total number of T allele, and N indicates the total number of T allele plus G allele.](pone.0059495.g007){#pone-0059495-g007}

![Forest plot of the association between rs12255372G/T polymorphism and T2DM risk (subgroup analyses for the southern China: T vs. G).\
n indicates the total number of T allele, and N indicates the total number of T allele plus G allele.](pone.0059495.g008){#pone-0059495-g008}

The subgroups analysis of the studies based on age, sex, and BMI was not carried out due to the extreme heterogeneity (*I^2^* = 80%) of sex comparability subgroup and insufficient studies with regard to the age and BMI comparability.

Association between rs290487T/C Polymorphism and T2DM Risk {#s3d}
----------------------------------------------------------

Significant heterogeneity was also observed among the studies of rs290487T/C in the overall meta-analysis. Hence the random effect model was chosen to illustrate the association between rs290487T/C polymorphism and T2DM risk. The result confirmed that rs290487C/T polymorphism was not associated with T2DM risk (as shown in [Fig. 9](#pone-0059495-g009){ref-type="fig"}, C vs. T: *OR* = 1.08, 95% *CI* = 0.93--1.25, *P* = 0.33; heterogeneity test *χ* ^2^ = 26.24, *P = *0.0005, *I^2^* = 73%).

![Forest plot of the association between rs290487T/C polymorphism and T2DM risk (overall meta-analysis C vs. T).\
n indicates the total number of C allele, and N indicates the total number of C allele plus G allele.](pone.0059495.g009){#pone-0059495-g009}

Based on the subgroup analyses with HWE in the control groups, we did not find any association between rs290487T/C polymorphism and T2DM risk (as shown in [Fig. 10](#pone-0059495-g010){ref-type="fig"} *OR* = 1.06, 95% *CI* = 0.89--1.26, *P* = 0.50; heterogeneity test *χ* ^2^ = 24.67, *P* = 0.0004, *I^2^* = 76%). Both the subgroup meta-analysis of the southern or the northern China indicated that there was no significant association between rs290487T/C polymorphism and T2DM risk (as shown in [Fig. 11](#pone-0059495-g011){ref-type="fig"}, in the northern China:*OR = *1.03, 95% *CI* = 0.80--1.33, *P* = 0.82; heterogeneity test *χ* ^2^ = 7.99, *P* = 0.02, *I^2^* = 75%; as shown in [Fig. 12](#pone-0059495-g012){ref-type="fig"}, in the southern China: *OR* = 1.11, 95% *CI* = 0.91--1.35, *P* = 0.32; heterogeneity test *χ* ^2^ = 16.08, *P* = 0.003, *I^2^* = 75%).

![Forest plot of the association between rs290487 T/C polymorphism and T2DM risk (subgroup analyses for the HWE in the control groups: C vs. T).\
n indicates the total number of C allele, and N indicates the total number of C allele plus G allele.](pone.0059495.g010){#pone-0059495-g010}

![Forest plot of the association between rs290487 T/C polymorphism and T2DM risk (subgroup analyses for the northern China: C vs. T).\
n indicates the total number of C allele, and N indicates the total number of C allele plus G allele.](pone.0059495.g011){#pone-0059495-g011}

![Forest plot of the association between rs290487 T/C polymorphism and T2DM risk (subgroup analyses for the southern China: C vs. T).\
n indicates the total number of C allele, and N indicates the total number of C allele plus G allele.](pone.0059495.g012){#pone-0059495-g012}

The subgroup meta-analysis of the studies based on age illustrated that there was no significant association between rs290487T/C polymorphism and T2DM risk (the subgroup of age comparability: *OR* = 1.02, 95% *CI* = 0.85--1.22, *P* = 0.83; heterogeneity test *χ* ^2^ = 15.56, *P* = 0.008, *I^2^* = 68%). The subgroup analysis of age incomparability was not conducted because of insufficiency studies.

The subgroup meta-analysis of the studies based on sex illustrated that this association was not affected by sex (the subgroup of sex comparability: *OR* = 1.07, 95% *CI* = 0.87--1.33, *P* = 0.51; heterogeneity test *χ* ^2^ = 12.83, *P* = 0.01, *I^2^* = 69%; the subgroup of sex incomparability: *OR* = 1.08, 95% *CI* = 0.85--1.58, *P* = 0.51; heterogeneity test *χ* ^2^ = 11.94, *P* = 0.003, *I^2^ = *83%). On the other hand, the subgroup meta-analysis based on BMI showed that the association was affected by this cofounder factor (the subgroup of BMI comparability: *OR* = 1.01, 95% *CI = *0.79--1.28, *P = *0.96; heterogeneity test *χ* ^2 = ^13.51, *P* = 0.004, *I^2^* = 78%; the subgroup of BMI incomparability: *OR = *1.19, 95% *CI* = 1.07--1.31, *P* = 0.0009; heterogeneity test *χ* ^2^ = 3.42, *P* = 0.33, *I^2^* = 12%).

Sensitivity Analysis {#s3e}
--------------------

By omitting one case--control study at a time and computing the pooled ORs for the remaining studies, we found that no single study could change the pooled results (as shown in [Table 5](#pone-0059495-t005){ref-type="table"}, [Table 6](#pone-0059495-t006){ref-type="table"}, and [Table 7](#pone-0059495-t007){ref-type="table"}). That is to say, our results of meta-analysis were very reliable.

10.1371/journal.pone.0059495.t005

###### The result of sensitivity analysis with each study omitted for rs7903146C/T.

![](pone.0059495.t005){#pone-0059495-t005-5}

  Study omitted     OR      95% CI         P
  --------------- ------ ------------ -----------
  Chang            1.86   1.54--2.25   \<0.00001
  Lin              1.76   1.36--2.27   \<0.0001
  Lou              1.74   1.37--2.22   \<0.00001
  NgMc             1.77   1.41--2.24   \<0.00001
  Zhang^1^         1.69   1.34--2.13   \<0.00001
  Wen.             1.58   1.38--1.81   \<0.00001
  Ren              1.75   1.37--2.23   \<0.00001
  Zhang^2^         1.75   1.39--2.22   \<0.00001
  Zeng             1.71   1.36--2.14   \<0.00001
  Wang             1.68   1.33--2.13   \<0.0001
  Zhao             1.70   1.36--2.13   \<0.0001
  Zheng            1.76   1.39--2.22   \<0.00001
  Chen             1.72   1.35--2.20   \<0.0001

Abbreviations: OR, odds ratio; CI, confidence interval.

Zhang^1^: XL Zhang; Zhang^2^: L Zhang.

10.1371/journal.pone.0059495.t006

###### The result of sensitivity analysis for rs12255372G/T.

![](pone.0059495.t006){#pone-0059495-t006-6}

  Study omitted     OR      95% CI      P
  --------------- ------ ------------ ------
  Chang.           1.84   0.77--4.38   0.17
  Fan.             1.26   0.81--1.95   0.30
  Ren.             2.04   0.89--4.66   0.09
  Wang.            1.93   0.79--4.68   0.15
  Zhang.           1.95   0.77--4.80   0.16

Abbreviations: OR, odds ratio; CI, confidence interval.

10.1371/journal.pone.0059495.t007

###### The result of sensitivity analysis for rs290487 T/C.

![](pone.0059495.t007){#pone-0059495-t007-7}

  Study omitted     OR      95% CI      P
  --------------- ------ ------------ ------
  Chang            1.04   0.89--1.22   0.59
  Qiao             1.12   0.97--1.30   0.11
  Ren              1.06   0.89--1.26   0.50
  Yu               1.10   0.93--1.29   0.28
  Zhang^1^         1.07   0.91--1.26   0.41
  Zhang^2^         1.12   0.96--1.30   0.14
  Zhu              1.04   0.89--1.21   0.62
  Zou              1.06   0.90--1.24   0.47

Abbreviations: OR, odds ratio; CI, confidence interval.

Zhang^1^ : Yong Zhang; Zhang^2^ : Ying Zhang.

The sensitivity analysis of the studies on rs7903146 showed no heterogeneity, if omitting the studies by Chang [@pone.0059495-Chang1], Ng [@pone.0059495-Ng1], and Wen [@pone.0059495-Wen1] from the total studies (as shown in [Fig. 13](#pone-0059495-g013){ref-type="fig"}, heterogeneity test *χ* ^2^ = 6.71, *P* = 0.67, *I^2^* = 0%). For this reason, we evaluated the association between rs7903146C/T polymorphism and T2DM risk by the fixed-effect model, and the interaction was confirmed (as shown in [Fig. 13](#pone-0059495-g013){ref-type="fig"}, T vs. C: *OR* = 1.72, 95% *CI* = 1.48--2.00, *P*\<0.00001). For the sensitivity analysis of rs12255372, if omitting the study of Fan [@pone.0059495-Fan1], the association between rs12255372 polymorphism and T2DM risk was not found (as shown in [Fig. 14](#pone-0059495-g014){ref-type="fig"}, T vs. G: *OR* = 1.26, 95%*CI* = 0.81--1.95, *P* = 0.30; heterogeneity test *χ* ^2^ = 0.37, *P* = 0.95, *I^2^* = 0%).

![Forest plot of the association between rs7903146C/T polymorphism and T2DM risk (sensitivity analysis: T vs. C).\
n indicates the total number of T allele, and N indicates the total number of T allele plus C allele.](pone.0059495.g013){#pone-0059495-g013}

![Forest plot of the association between rs12255372G/T polymorphism and T2DM risk (sensitivity analysis: T vs. G).\
n indicates the total number of T allele, and N indicates the total number of T allele plus G allele.](pone.0059495.g014){#pone-0059495-g014}

Publication Bias {#s3f}
----------------

The shape of the funnel plots on the studies of rs7903146C/T polymorphism was symmetrical, suggesting that there was no evidence of publication bias for rs7903146C/T polymorphism (as shown in [Figure 15](#pone-0059495-g015){ref-type="fig"}). We did not make funnel plots for the other two single nucleotide polymorphisms (SNPs) due to the limited studies on rs12255372G/T and rs290487T/C.

![Funnel plots analysis to detect publication bias (T vs. C of rs7903146C/T polymorphism).\
Each point represents an independent study for the indicated association.Tables.](pone.0059495.g015){#pone-0059495-g015}

Discussion {#s4}
==========

It has been widely accepted that TCF7L2 gene is associate with T2DM risk in different ethnic groups [@pone.0059495-Cauchi1], [@pone.0059495-Lyssenko1]--[@pone.0059495-Potapov1], [@pone.0059495-Hayashi1]--[@pone.0059495-Palizban1]. Till now, no consistent results in Chinese Han population have been obtained. Chen [@pone.0059495-Chen1], Lin [@pone.0059495-Lin1], and Zhao [@pone.0059495-Zhao1] confirmed that there was association between the rs7903146 variant of TCF7L2 and T2DM risk in Chinese Han population. On the other hand, Chang [@pone.0059495-Chang1], Ng [@pone.0059495-Ng1], and Zheng [@pone.0059495-Zheng1] presented contrary conclusion. For resolving the conflict of all these studies, we employed a meta-analysis method to improve statistical power by pooling the related samples.

The study by Lou [@pone.0059495-Lou2] indicated that four SNPs of TCF7L2 (rs7903146, rs12255372, rs11196205, and rs290487) were associated with T2DM risk in East Asian. Due to limited amounts of studies on SNPs of TCF7L2 in Chinese Han population, only three SNPs (rs7903146C/T, rs12255372G/T, and rs290487T/C) were analyzed in our meta-analysis. Our analysis indicated that rs7903146C/T polymorphism was significantly associated with T2DM risk in Chinese Han population, which is consistent with the studies in Europe [@pone.0059495-Scott1]--[@pone.0059495-vanVlietOstaptchouk1] and East Asian [@pone.0059495-Lou2]. The T allele at rs7903146 appeared to be one of the genetic risk factors for susceptibility to T2DM. On the other hand, we did not found any evidence that the association between T2DM risk and the other two SNPs (rs12255372G/T and rs290487T/C). It should be noted that this result is not consistent with the studies in Europe [@pone.0059495-Scott1]--[@pone.0059495-vanVlietOstaptchouk1] and East Asian [@pone.0059495-Lou2]. These discrepancies can be attributed to the difference between genetic backgrounds of ethnic and population substructure. Another possible explanation is that a lower risk allele frequency in Chinese Han population would be unlinked to the T2DM in spite of apparent association at the markers [@pone.0059495-InternationalHapMap1].

Compared with Europe population, there is a rather small genetic diversity in Chinese Han population [@pone.0059495-Xu3]. Despite all that, Pritchard [@pone.0059495-Pritchard1] [i]{.ul}llustrated that small diversity may be sufficient to lead to an inflated rate of false-positive results. In other words, the intricate substructure of Han Chinese may cause spurious association between polymorphism and T2DM risk. Xu [@pone.0059495-Xu2] showed that there was the greatest genetic differentiation of Chinese Han population between the northern Han Chinese (NHC) and the southern Han Chinese (SHC) based on the genetic boundary of Yangtze River. Therefore, it is necessary to evaluate the effect of population substructure on the association between SNP of TCF7L2 and T2DM risk. A subgroup meta-analysis was utilized to explore the effect of the population substructure on the overall estimation of the association. Our analysis indicated that there was no association between SHC and NHC. On the other hand, the analysis result also reflected the heterogeneity among the included studies by heterogeneity test. We found that this heterogeneity of rs7903146 resulted from the studies by Chang [@pone.0059495-Chang1], Ng [@pone.0059495-Ng1], and Wen [@pone.0059495-Wen1], while the heterogeneity of rs12255372 was attributed to the study by Fan [@pone.0059495-Fan1]. As for rs7903146, the populations of the involved three studies resided in metropolis of Taiwan, HongKong and Shanghai, respectively. The residents in these bigalopolis emigrated from the different areas of China, and thus should not be regarded as one single homogenous population owing to historical immigrations, complex ancestries, population movements, and recent intermarriages with other ethnic groups in the three metropolises [@pone.0059495-Xu2]. For this reason, our analysis may be affected by the intricate substructure in Han Chinese. Therefore, this is a feasible explanation for that the heterogeneity was observed from the study in the metropolis of Shanghai, but not found from the neighboring province of Jiangsu, despite both populations being SHC. With regard to rs12255372, Fan and his colleagues [@pone.0059495-Fan1] illustrated that there was a significant association of rs12255372 with T2DM risk. This result was conflicted with other results [@pone.0059495-Chang1]--[@pone.0059495-Zhang1], [@pone.0059495-Wang1]. We considered this conflict may result from small samples, relatively low comparability between the cases and controls, difference in genotyping method, substructure of population, and some other unknown factors.

Besides the above mentioned population substructure, other confounder factors such as age, sex, BMI, environment, and ethnic may affect the study results of T2DM, since it is a complex hereditary disease. However, among all the studies included in our meta-analysis, only Lin [@pone.0059495-Lin1], Chang [@pone.0059495-Chang1], and Wang [@pone.0059495-Wang1] demonstrated that the association between rs7903146C/T polymorphism and T2DM risk remained significant after adjustment for the combined confounders of age, sex, and BMI. This suggested that their effects on diabetes were not primarily mediated through adiposity [@pone.0059495-Chang1]. Given most of the cases were not comparable with the controls on the age, sex, and BMI, it would be perfect to consider these factors in our meta-analysis. However, this was rarely achieved due to insufficient raw data. In spite of that, we employed subgroup analysis to evaluate the effect of some confounders like age, sex, and BMI on the pooled OR. The result indicated that the association of rs290487 with T2DM was influenced by BMI, whereas neither age nor sex affected the association of rs7903146 and rs290487 with T2DM.

The advantages of our meta-analysis can be summarized as follows. First of all, to the best of our knowledge, this is the most comprehensive meta-analysis for the association between TCF7L2 polymorphism (rs7903146C/T, rs12255372G/T and rs290487T/C) and T2DM risk in Chinese Han populations. The protocol of this meta-analysis has been well designed primitively by using explicit methods and criteria for study selection, data extraction, and data analysis. Perfect searching strategy based on computer-assisted search together with manual search has been applied to include eligible studies as many as possible. Finally, the quality of included studies in our meta-analysis is relatively satisfactory. Since the number of studies and subjects included in our meta-analysis were relatively small, however, the funnel plots could not be made in the two SNPs (rs12255372G/T and rs290487T/C), which could not avoid possible publication bias in our analysis.

In conclusion, this meta-analysis indicated that, in Chinese Han population, the rs7903146C/T polymorphism of TCF7L2 gene was associated with T2DM risk, while the polymorphisms of rs12255372G/T and rs290487T/C were not**.** We expect that the case-control studies with large and family-based samples had better be carried out in the future to provide sufficient data for better meta-analysis, considering low frequency of TCF7L2 gene, a variety of confounders, and two substructures in Chinese Han.
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